Improving vaccine efficacy against malignant glioma

The effective treatment of adult and pediatric malignant glioma is a significant clinical challenge. In adults, glioblastoma (GBM) accounts for the majority of malignant glioma diagnoses with a median survival of 14.6 mo. In children, malignant glioma accounts for 20% of primary CNS tumors with a me...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Ladomersky, Erik, Genet, Matthew, Zhai, Lijie, Gritsina, Galina, Lauing, Kristen L., Lulla, Rishi R., Fangusaro, Jason, Lenzen, Alicia, Kumthekar, Priya, Raizer, Jeffrey J., Binder, David C., James, C. David, Wainwright, Derek A.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007967/
https://ncbi.nlm.nih.gov/pubmed/27622066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1196311
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados